# IONIS PHARMACEUTICALS INC (IONS)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/IONS/

- Reporting holders: 10
- Reported value: $525.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Wedmont Private Capital](https://holderbook.com/funds/1904274-wedmont-private-capital/) | $277.1K | 6,400 | 0.0% | 6 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $89.3K | 2,000 | 0.0% | 32 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $78.7K | 1,763 | 0.0% | 12 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $32.7K | 732 | 0.0% | 16 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $16.5K | 370 | 0.0% | 9 |
| [EASTERN BANK](https://holderbook.com/funds/1126395-eastern-bank/) | $13.4K | 300 | 0.0% | 7 |
| [Trust Co](https://holderbook.com/funds/1632554-trust-co/) | $11.2K | 250 | 0.0% | 2 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $5.5K | 124 | 0.0% | 21 |
| [Planning Strategies Inc.](https://holderbook.com/funds/2139665-planning-strategies-inc/) | $536 | 12 | 0.0% | 2 |
| [GILPIN WEALTH MANAGEMENT, LLC](https://holderbook.com/funds/2058144-gilpin-wealth-management-llc/) | $45 | 1 | 0.0% | 1 |
| [CX Institutional](https://holderbook.com/funds/1737089-cx-institutional/) | $2 | 46 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 10 | $525.0K |
| Q2 2026 | 522 | $15.5B |
| Q1 2026 | 496 | $13.3B |
| Q4 2025 | 499 | $14.2B |
| Q3 2025 | 446 | $11.3B |
| Q2 2025 | 369 | $6.8B |
| Q1 2025 | 349 | $5.1B |
| Q4 2024 | 362 | $5.7B |
| Q3 2024 | 357 | $6.4B |
| Q2 2024 | 360 | $7.1B |
| Q1 2024 | 362 | $6.4B |
| Q4 2023 | 367 | $7.4B |